These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 19152363
1. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. Sorbi C, Franchini S, Tait A, Prandi A, Gallesi R, Angeli P, Marucci G, Pirona L, Poggesi E, Brasili L. ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363 [Abstract] [Full Text] [Related]
2. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors. Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L. Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276 [Abstract] [Full Text] [Related]
3. 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists. Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E. J Med Chem; 2003 Apr 10; 46(8):1504-11. PubMed ID: 12672251 [Abstract] [Full Text] [Related]
4. 1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands. Tait A, Luppi A, Franchini S, Preziosi E, Parenti C, Buccioni M, Marucci G, Leonardi A, Poggesi E, Brasili L. Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1185-8. PubMed ID: 15686938 [Abstract] [Full Text] [Related]
5. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors. Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L. J Med Chem; 2012 Jan 12; 55(1):23-36. PubMed ID: 22145629 [Abstract] [Full Text] [Related]
6. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D. J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407 [Abstract] [Full Text] [Related]
7. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics. Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878 [Abstract] [Full Text] [Related]
8. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation. Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G. J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148 [Abstract] [Full Text] [Related]
9. Alpha1-adrenoceptor antagonists. 6. Structural optimization of pyridazinone-arylpiperazines. Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety. Betti L, Corelli F, Floridi M, Giannaccini G, Maccari L, Manetti F, Strappaghetti G, Botta M. J Med Chem; 2003 Jul 31; 46(16):3555-8. PubMed ID: 12877594 [Abstract] [Full Text] [Related]
10. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus. Fiorino F, Severino B, De Angelis F, Perissutti E, Frecentese F, Massarelli P, Bruni G, Collavoli E, Santagada V, Caliendo G. Arch Pharm (Weinheim); 2008 Jan 31; 341(1):20-7. PubMed ID: 18072244 [Abstract] [Full Text] [Related]
11. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands. Siracusa MA, Salerno L, Modica MN, Pittalà V, Romeo G, Amato ME, Nowak M, Bojarski AJ, Mereghetti I, Cagnotto A, Mennini T. J Med Chem; 2008 Aug 14; 51(15):4529-38. PubMed ID: 18598015 [Abstract] [Full Text] [Related]
12. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes. Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C. J Med Chem; 1999 Jul 29; 42(15):2961-8. PubMed ID: 10425105 [Abstract] [Full Text] [Related]
13. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists. Balle T, Perregaard J, Ramirez MT, Larsen AK, Søby KK, Liljefors T, Andersen K. J Med Chem; 2003 Jan 16; 46(2):265-83. PubMed ID: 12519065 [Abstract] [Full Text] [Related]
14. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity. Bojarski AJ, Paluchowska MH, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Bioorg Med Chem; 2006 Mar 01; 14(5):1391-402. PubMed ID: 16266808 [Abstract] [Full Text] [Related]
15. (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist. Franchini S, Tait A, Prandi A, Sorbi C, Gallesi R, Buccioni M, Marucci G, De Stefani C, Cilia A, Brasili L. ChemMedChem; 2009 Feb 01; 4(2):196-203. PubMed ID: 19101959 [Abstract] [Full Text] [Related]
16. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes. Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP. J Med Chem; 2003 Jul 03; 46(14):2877-94. PubMed ID: 12825930 [Abstract] [Full Text] [Related]
17. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity. Zhang J, Zhang H, Cai W, Yu L, Zhen X, Zhang A. Bioorg Med Chem; 2009 Jul 15; 17(14):4873-80. PubMed ID: 19559623 [Abstract] [Full Text] [Related]
18. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands. López-Rodríguez ML, Benhamú B, Morcillo MJ, Tejada I, Avila D, Marco I, Schiapparelli L, Frechilla D, Del Río J. Bioorg Med Chem; 2004 Oct 01; 12(19):5181-91. PubMed ID: 15351401 [Abstract] [Full Text] [Related]
19. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors. López-Rodríguez ML, Morcillo MJ, Fernández E, Benhamú B, Tejada I, Ayala D, Viso A, Campillo M, Pardo L, Delgado M, Manzanares J, Fuentes JA. J Med Chem; 2005 Apr 07; 48(7):2548-58. PubMed ID: 15801844 [Abstract] [Full Text] [Related]
20. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor. Perrone R, Berardi F, Colabufo NA, Lacivita E, Larizza C, Leopoldo M, Tortorella V. J Pharm Pharmacol; 2005 Oct 07; 57(10):1319-27. PubMed ID: 16259761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]